Diagnosis of SARS-CoV-2 infections in times of material shortage

Author:

Sandri Thaisa Lucas,Inoue Juliana,Geiger Johanna,Griesbaum Johanna-Marie,Heizel Constanze,Burnet Michael,Fendel Rolf,Kremsner Peter G.,Held Jana,Kreidenweiss AndreaORCID

Abstract

AbstractThe pandemic caused by SARS-CoV-2 resulted in increasing demands for diagnostic tests, leading to a shortage of recommended testing materials and reagents. This study reports on the performance of self-sampled alternative swabbing material (ordinary Q-tips tested against flocked swab and rayon swab), of reagents for classical RNA extraction (phenol/guanidine-based protocol against a commercial kit), and of intercalating dye-based one-step quantitative reverse transcription real-time PCRs (RT-qPCR) compared against the gold standard hydrolysis probe-based assays for SARS-CoV-2 detection. The study found sampling with Q-tips, RNA extraction with classical protocol and intercalating dye-based RT-qPCR as a reliable and comparably sensitive strategy for detection of SARS-CoV-2 - particularly valuable in the current period with a resurgent and dramatic increase in SARS-CoV-2 infections and growing shortage of diagnostic materials as well for regions limited in resources.

Publisher

Cold Spring Harbor Laboratory

Reference12 articles.

1. Patel R , Babady E , Theel ES , Storch GA , Pinsky BA , St George K , Smith TC , Bertuzzi S. 2020. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19. MBio. NLM (Medline).

2. Cheng MP , Papenburg J , Desjardins M , Kanjilal S , Quach C , Libman M , Dittrich S , Yansouni CP . 2020. Diagnostic Testing for Severe Acute Respiratory Syndrome– Related Coronavirus-2. Ann Intern Med https://doi.org/10.7326/M20-1301.

3. WHO. 2020. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases. https://apps.who.int/iris/bitstream/handle/10665/331329/WHO-COVID-19-laboratory-2020.4-eng.pdf. Accessed 15/04/2020. 1–7.

4. ECDC. 2020. Laboratory support for COVID-19 in the EU/EEA. Eur Cent Dis Prev Control.

5. CDC. 2020. Interim Guidelines for Clinical Specimens for COVID-19 | CDC. Centers Dis Control Prev 2019:1–5.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3